Equillium, Inc. (EQ)
Equillium, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Equillium, Inc. (EQ) is a Biotechnology company based in US with a market capitalization of $88.4M. Free cash flow was negative at -$22.8M. This page tracks EQ's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 35 employees · IPO Oct 12, 2018
Valuation
Valuation & price
$2.18as of May 17, 2026· -31.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
3.09
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$88.4M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$22.8M
Free cash flow (USD)
-$29.6M
Net debt
Net cash position
159.9%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2022 → 2024
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
4
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 5, 2026Filing
Insider Sell $724KConnelly Stephen · President and CSO · $723.8K
- Insider sellJun 5, 2026Filing
Insider Sell $43K · 10b5-1 PlanZedelmayer Christine · Sr. Vice President and COO · $42.7K
- Insider sellMay 29, 2026Filing
Insider Sell $267K · 10b5-1 PlanZedelmayer Christine · Sr. Vice President and COO · $267.2K
- Insider sellMay 29, 2026Filing
Insider Sell $192K · 10b5-1 PlanTom Penny · Principal Accounting Officer · $191.8K
- 8-K eventMay 29, 2026Filing
Annual Meeting Results
- 8-K eventMay 13, 2026Filing
CFO Appointment
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- FinancingApr 7, 2026Filing
Securities Registration
Questions
Frequently asked questions
What is Equillium, Inc.'s market cap?
Equillium, Inc. (EQ) has a market capitalization of $88.4M.
What is EQ's P/E ratio?
A meaningful P/E ratio is not available for EQ — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is EQ's price-to-book (P/B) ratio?
EQ trades at 3.09 times book value per share.
Are insiders buying EQ stock?
SEC Form 4 filings show no open-market insider buys at Equillium, Inc. in the last 90 days (4 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.